Navigation Links
Ohio State University Medical Center to Test Efficacy of Hyperbaric Oxygen Medicine on Stroke Victims
Date:5/20/2008

ANAHEIM, Calif., May 20 /PRNewswire/ -- With the financial support of Sechrist Industries, Inc., The Center for Minimally Invasive Surgery (CMIS) at the Ohio State University Medical Center has begun testing the efficacy of hyperbaric oxygen medicine on experimental stroke models. CMIS is a multidisciplinary center dedicated to excellence in patient care, clinical training, research and outcomes studies pertaining to the techniques and technology of minimally invasive surgery.

Currently utilized for the treatment of chronic, non-healing wounds, carbon monoxide poisoning, crush injuries as well as other indications, the use of hyperbaric medicine for stroke victims is at the forefront of hyperbaric research. Hyperbaric oxygen therapy is the treatment of the entire body with 100-percent oxygen at greater than normal atmospheric pressures. Hyperbaric medicine greatly increases oxygen concentration in all body tissues, even with reduced or blocked blood flow, stimulates the growth of new blood vessels to locations with reduced circulation (improving blood flow to areas with arterial blockage) and causes a rebound arterial dilation after treatment, resulting in an increased blood vessel diameter greater than when therapy began, thus improving blood flow to compromised organs. The CMIS team is hopeful that these benefits of hyperbaric oxygen treatments will positively affect stroke patients.

"Ohio State University Medical Center is one of the finest health care institutions in the country," stated Jack Rollins, President and CEO of Sechrist Industries, Inc. "As the world leader in hyperbaric oxygen technology, we feel that it is important to join forces with CMIS to support research in the field of hyperbaric medicine."

"We believe that there is a window of opportunity to treat stroke related injury of the brain using hyperbaric oxygen. The challenge lies in accurately defining the perimeters of that window," says Chandan Sen, Director of the C
'/>"/>

SOURCE Sechrist Industries, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Data re-analysis shows drug finasteride reduces risk for most prostate cancers
2. Forty-Two Free Clinics Across State Share $1 Million in Grants From Blue Cross Blue Shield of Michigan
3. Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx
4. Mapping of prostate cancer genes opens the door to new treatments
5. Radiation for Prostate Cancer Raises Risk of Other Cancers
6. MR imaging accurately determines prostate cancer treatment failure
7. ACS Expands State Medicaid Presence with $156 Million Tennessee Contract
8. New data show benefit of finasteride in preventing prostate cancer
9. Prostate Cancer Vaccine Looks Promising in Early Trial
10. AUDIO from Medialink, Oral Health America & Philips Sonicare: National Smile Month - Giving Americans Something to Smile About Survey Reveals State of Americans Oral Health
11. Paramedics, EMTs in Oregon, Washington State Ratify First-Ever Teamsters Contract

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...EW ORLEANS, Dec. 1 The ... annual High School Student Symposium at the New O....m. CST. The symposium, which encourages an intere...ical research, is held in conjunction with the Soc...ll have the opportunity to explore research on sic...
(Date:12/1/2009)... BANK, N.J., Dec. 1 A national sur...ding is ideal for their babies and themselves but ...ks best for them and their families. ,, See vid...IFC_37156/ ,, The survey of mothers of childre...rs (83%) made their infant feeding decision prior ...
(Date:12/1/2009)...d in development of simple screening test, expert ...) -- In a finding that could lead to a simple bloo... have identified immune system markers that indica...for lung cancer. , The researchers examined gen...ople with non-small cell lung cancer and a contro...
(Date:12/1/2009)...cination because pandemic,s course remains unpredi...ws) -- A U.S. health official said Tuesday that H1...ationally, but many experts agreed the virus could...s now widespread in 32 states -- down from 43 stat...r of the U.S. Centers for Disease Control and Prev...
(Date:12/1/2009)... Ever thought you could quit smoking while ...ith,s groundbreaking new system for quitting is ea...just twenty eight days your cravings and desire to... (PRWEB) December 1, 2009 -- Izabella ha...ear addiction to nicotine, smoking at least a pack...
Breaking Medicine News(10 mins):Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:VIDEO from Medialink and HealthyWomen: Breast, Bottle or Both? 2Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3
...l new studies on genetics and stem cell research, ... of stents to clear coronary artery blockages are ...nd stroke for 2007, said Daniel W. Jones, M.D., pr...opulmonary resuscitation. , The American Heart Ass...
...N, Dec. 20 The following is being,issued by Cente...pproaching, millions of Americans are preparing,to...tree-trimming, and,leaving cookies and milk out fo...of a very un-merry obesity lawsuit., Before he wo...
...b., Dec. 20 Alegent Health is once,again taking t... making it,possible for consumers on the go to rec...tions -- even pictures of newborns delivered at on...nd PDAs,to access., "The latest research suggests...
...ES, Dec. 20 By a landslide 87 percent vote,regist... the Los Angeles,area Wednesday night elected the ...ses Association/National Nurses Organizing Committ...NNOC will represent 300 RNs at,the hospital., Fol...
...DGE, Tenn., Dec. 20, 2007 -- A Las Vegas business ...e odds for people medically at risk from dehydrati...NL researchers Chuck Britton, Nance Ericson and Ga...his is of great importance to members of the milit...
..., N.C., Dec. 20 MedCath Corporation,(Nasdaq: MDT...ned as,Executive Vice President and Chief Financia...r Charlotte, N.C. based Coca-Cola Bottling Co.,Con...ll remain with MedCath until near the end of Janua...
Other Medicine News:Health News:Top10 research advances include studies on genetics and stem cell research, stents 2Health News:Top10 research advances include studies on genetics and stem cell research, stents 3Health News:Top10 research advances include studies on genetics and stem cell research, stents 4Health News:Top10 research advances include studies on genetics and stem cell research, stents 5Health News:Center for Consumer Freedom Releases 'Don't Sue Me Santa' Christmas Cookie Liability Waiver 2Health News:Alegent.com Goes Mobile 2Health News:Whittier Hospital RNs Choose CNA/NNOC in Landslide 87% Election Victory 2Health News:Nevada company, ORNL develop potential lifesaver 2Health News:James E. Harris to Become Chief Financial Officer of Coca-Cola Bottling Co. Consolidated 2
(Date:12/1/2009)...., Dec. 1 Former New Jer...elighted when his radiotherapy treatment sessions ...h day to less than five. Midway through his cours...ology Cancer Center acquired the region,s first ...an Medical Systems (NYSE: VAR ), making it possi...
(Date:12/1/2009)..., Dec. 1 The educational...h... Improving Life," created by Lilly USA (NYSE: ...alth.com/value_of_medicine.jsp . The booklet suppo...Matter" and encourages an open dialogue with patie...ceutical industry practices. ,, "Today, Lilly ...
(Date:12/1/2009)...e-FirstCall/ -- WebMD Health Corp. (Nasdaq: WBMD ... announced the honorees of the 2009 WebMD Health H...s honor Americans with extraordinary stories of pe...t to help others achieve better health. ,, ...1201/NY18114 ) ,, "WebMD is honoring its 2009 ...
Breaking Medicine Technology:Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 3Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 4WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 3ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities 5342 1ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities 5342 2ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities 5342 3Mirixa Corporation Announces Key Pharmacy Network Hire 5339 1Mirixa Corporation Announces Key Pharmacy Network Hire 5339 2AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform 5336 1AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform 5336 2
...nical Trial in Type 2,Diabetes Patients Announced,...ransition,Therapeutics Inc. ("Transition") , today...IIa clinical trial indicating that 4-weeks of,dail...(TM), showed,sustained reductions in blood glucose...1c), for 6 months post-treatment. The type 2,diabe...
...07 - Cytogen,Corporation (NASDAQ: CYTO) reported u...valuating QUADRAMET(R) (samarium Sm-153,lexidronam...e(R),Millennium Pharmaceuticals, Inc.) in patient...ients were presented today in a,poster titled, "Ph... in Multiple Myeloma," by James Berenson, M.D., Me...
Other Medicine Technology:A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 2A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 3A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 4A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 5Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 2Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 3Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 4Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 5Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 6Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 7Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 8
Genesis II Patellar Instruments
NexGen Complete Knee Solution IM Instrumentation
MIS Tibial Saw Guide
MIS Distal Femoral Alignment/Saw Guide and Intramedullary Rod
Medicine Products: